SENO CJC-1295 + Ipamorelin Polvo Liofilizado Precio al por mayor al por mayor

Descripción

Dual-Pathway GH/IGF-1 Research Peptide for Endocrine & Metabolic Studies

SENO CJC-1295 + Ipamorelin is a high-purity combination research péptido supplied as lyophilized powder for advanced laboratory investigations involving growth hormone signaling, endocrine regulation, receptor-mediated pathways, and metabolic research models.

This peptide formulation combines:

  • CJC-1295 — a GHRH (Growth Hormone Releasing Hormone) analog
  • Ipamorelin — a selective growth hormone secretagogue

The dual-mechanism design enables synergistic investigation of GH/IGF-1 axis modulation and receptor signaling interactions in controlled laboratory environments.

Especificaciones disponibles:

  • CP10 — 10mg × 10 vials

Each batch is manufactured using automated solid-phase peptide synthesis (SPPS), followed by analytical verification using HPLC and mass spectrometry to support purity, structural integrity, and batch reproducibility.

Este producto se suministra exclusivamente para aplicaciones de investigación en laboratorio.


What Is CJC-1295 + Ipamorelin?

CJC-1295 + Ipamorelin is a combination peptide formulation developed for research involving growth hormone regulatory pathways.

CJC-1295 Component

CJC-1295 is a synthetic GHRH analog investigated for its interaction with growth hormone releasing hormone receptors and downstream endocrine signaling mechanisms.

Research involving CJC-1295 commonly focuses on:

  • GH secretion signaling
  • pituitary receptor activation
  • modulación de la vía endocrina
  • IGF-1 regulatory studies

Ipamorelin Component

Ipamorelin is a selective growth hormone secretagogue studied for its interaction with ghrelin-related receptor pathways and growth hormone release signaling.

Laboratory investigations may involve:

  • receptor-binding studies
  • secretagogue pathway analysis
  • endocrine signaling dynamics
  • peptide-receptor interaction models

Combined together, the peptide blend allows researchers to study synergistic activation of GH/IGF-1-related signaling systems using complementary receptor mechanisms.

The formulation is supplied as a white to off-white lyophilized powder for enhanced stability during storage and transport.


Aplicaciones de la investigación

CJC-1295 + Ipamorelin is commonly utilized in laboratory investigations involving:

  • GH/IGF-1 axis research
  • endocrine signaling studies
  • receptor-mediated peptide interactions
  • growth hormone release pathway analysis
  • metabolic signaling investigations
  • peptide synergy research
  • farmacología de receptores
  • cellular signaling experiments
  • preclinical metabolic models
  • biochemical pathway investigations

Its dual-pathway mechanism makes it useful in studies involving coordinated endocrine and receptor-signaling systems.


Fórmula molecular

CJC-1295

C152H252N44O42C_{152}H_{252}N_{44}O_{42}

Ipamorelina

C38H49N9O5C_{38}H_{49}N_9O_5


Peso molecular

Approximate combined peptide molecular profile:

∼4.5 kDa\sim4.5\ kDa


Número CAS

ComponentNúmero CAS
CJC-1295863288-34-0
Ipamorelina170851-70-4

Especificaciones del producto

Código del productoEspecificaciónFormularioPurezaApariencia
CP1010mg × 10 vialsPolvo liofilizado≥98%Blanco a blanquecino

Mecanismo de acción

The CJC-1295 + Ipamorelin combination is studied for complementary activation of growth hormone-related signaling pathways.

CJC-1295 Pathway Activity

CJC-1295 is investigated as a GHRH receptor agonist that may influence:

  • pituitary signaling pathways
  • growth hormone secretion dynamics
  • comunicación endocrina
  • IGF-1 pathway modulation

Ipamorelin Pathway Activity

Ipamorelin is researched for selective interaction with ghrelin-related receptor systems involved in:

  • growth hormone release signaling
  • peptide-receptor interaction
  • endocrine pathway activation
  • metabolic signaling responses

The combined peptide system allows researchers to investigate coordinated endocrine signaling using dual receptor-mediated mechanisms.


Solubilidad

CJC-1295 + Ipamorelin is generally soluble in:

  • agua estéril
  • bacteriostatic water
  • solución salina tamponada con fosfato (PBS)
  • selected laboratory buffers

Suggested laboratory preparation volume:

2−3 mL per 10mg vial2{-}3\ mL\ per\ 10mg\ vial

Actual preparation concentration should be optimized according to individual experimental protocols and assay requirements.


Recomendaciones de almacenamiento

Para una estabilidad óptima del péptido:

  • Store lyophilized peptide at -20°C
  • Proteger de la humedad y la luz directa
  • Avoid repeated temperature fluctuations
  • Maintain sterile handling conditions

Después de la reconstitución:

  • Aliquot into sterile containers when possible
  • Store at 2–8°C or according to laboratory protocol
  • Minimizar los ciclos de congelación y descongelación
  • Use prepared solutions promptly

Información sobre estabilidad

The lyophilized formulation helps preserve structural integrity and reduce degradation risk during storage and transport.

Peptide stability may be affected by:

  • hidrólisis
  • oxidación
  • contaminación microbiana
  • ciclos repetidos de congelación y descongelación
  • temperature exposure
  • prolonged storage after reconstitution

Controlled storage conditions support reproducible experimental performance and peptide integrity.


Estudios de investigación e interés científico

CJC-1295 + Ipamorelin is widely investigated in endocrine and receptor-signaling research due to its complementary pathway activity.

Research areas commonly include:

  • GH/IGF-1 signaling mechanisms
  • endocrine regulation models
  • peptide synergy investigations
  • receptor-binding studies
  • growth hormone pathway analysis
  • metabolic signaling research
  • cellular communication pathways
  • preclinical endocrine studies

The dual-mechanism design provides researchers with a model for studying coordinated hormonal signaling interactions.


Fabricación y control de calidad

SENO manufactures CJC-1295 + Ipamorelin using automated solid-phase peptide synthesis (SPPS) under controlled laboratory conditions.

El flujo de trabajo de producción incluye:

  • pharmaceutical-grade amino acid sourcing
  • automated peptide sequence assembly
  • controlled coupling and deprotection cycles
  • preparative HPLC purification
  • mass spectrometry verification
  • sterile lyophilization procedures

Each batch undergoes analytical verification to support:

  • purity consistency
  • identidad molecular
  • integridad estructural
  • sequence fidelity
  • batch reproducibility

This manufacturing process helps ensure reliable performance in sensitive endocrine and receptor-signaling research applications.


COA (Certificado de análisis)

La documentación analítica puede incluir:

  • identificación de lotes
  • HPLC purity profile
  • verificación molecular
  • inspección de aspecto
  • fecha de fabricación
  • storage recommendations
  • aprobación del control de calidad

COA documentation supports laboratory traceability and internal quality assurance workflows.


Verificación por HPLC y espectrometría de masas

Each batch undergoes analytical testing using:

  • Cromatografía líquida de alto rendimiento (HPLC)
  • Espectrometría de masas (EM)

These analytical methods help verify:

  • peptide purity
  • identidad molecular
  • coherencia estructural
  • evaluación de impurezas
  • batch reproducibility

Analytical chromatograms and molecular verification data may be available for laboratory documentation purposes.


Guía de reconstitución

Procedimiento de laboratorio recomendado

  1. Allow vial to reach room temperature before opening.
  2. Seleccione el disolvente estéril apropiado para el protocolo de investigación.
  3. Añadir lentamente disolvente a lo largo de la pared del vial.
  4. Gently swirl until fully dissolved.
  5. Evitar agitar enérgicamente o hacer espuma.
  6. Aliquot into sterile containers if needed.
  7. Store prepared solutions according to laboratory requirements.

Researchers should optimize preparation concentrations according to specific experimental designs.


Precauciones de manipulación

  • Para uso exclusivo en investigación de laboratorio
  • No destinado a la administración humana o veterinaria
  • Use laboratory PPE during handling
  • Maintain aseptic preparation conditions
  • Evitar ciclos repetidos de congelación y descongelación
  • Dispose of materials according to institutional biosafety regulations

Información de envío

  • Worldwide FedEx or equivalent courier shipping
  • Lyophilized peptide supplied for improved transport stability
  • Ambient temperature shipping with protective packaging
  • Packaging designed to maintain vial integrity during international transport

Preguntas más frecuentes (FAQ)

What is CJC-1295 + Ipamorelin used for in research?

This peptide combination is commonly studied in GH/IGF-1 axis research, endocrine signaling investigations, receptor pharmacology, and metabolic pathway studies.


Why combine CJC-1295 and Ipamorelin?

The two peptides act through complementary receptor systems, allowing researchers to investigate synergistic endocrine signaling and coordinated growth hormone pathway activation.


Why is the peptide supplied in lyophilized form?

Lyophilization helps improve peptide stability by reducing moisture-related degradation during storage and transportation.


¿Qué métodos analíticos se utilizan para verificar la calidad?

Each batch is verified using HPLC and mass spectrometry to confirm purity, molecular identity, and structural consistency.


How should the peptide be stored?

Lyophilized peptide should generally be stored at -20°C. Reconstituted solutions should be handled carefully and protected from repeated freeze-thaw exposure.


Is this product intended for therapeutic or medical use?

No. SENO CJC-1295 + Ipamorelin is supplied strictly for laboratory research applications only and is not approved for human or veterinary administration.